{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:28:36Z","timestamp":1791646116296,"version":"4.3.4"},"reference-count":109,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.aohep.2019.11.010","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T11:49:51Z","timestamp":1577965791000},"page":"458-465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["NRF-2 and nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"19","author":[{"given":"Arturo","family":"Solano-Urrusquieta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Morales-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela E.","family":"Castro-Narro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eira","family":"Cerda-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perla D.","family":"Flores-Rangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Fierros-Oceguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.aohep.2019.11.010_bib0550","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/apt.15153","article-title":"Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis","volume":"49","author":"Regev","year":"2019","journal-title":"Alimentary Pharmacol Therap"},{"issue":"1","key":"10.1016\/j.aohep.2019.11.010_bib0555","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.aohep.2019.11.010_bib0560","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2019.11.010_bib0565","doi-asserted-by":"crossref","DOI":"10.20960\/nh.1317","article-title":"Inflammatory Cytokines and Non-Alcoholic Fatty Liver Disease (NAFLD) in obese children and adolescents","author":"Silvana","year":"2018","journal-title":"Nutrici\u00f3n Hospitalaria"},{"issue":"3","key":"10.1016\/j.aohep.2019.11.010_bib0570","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/hep.22716","article-title":"Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta\/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells","volume":"49","author":"Ruddell","year":"2008","journal-title":"Hepatology"},{"issue":"21","key":"10.1016\/j.aohep.2019.11.010_bib0575","doi-asserted-by":"crossref","first-page":"9926","DOI":"10.1073\/pnas.91.21.9926","article-title":"Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2\/AP1 repeat of the beta-globin locus control region","volume":"91","author":"Moi","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.aohep.2019.11.010_bib0580","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/mc.20465","article-title":"Molecular mechanisms of Nrf2-mediated antioxidant response","volume":"48","author":"Li","year":"2009","journal-title":"Mol Carcinog"},{"issue":"29","key":"10.1016\/j.aohep.2019.11.010_bib0585","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1038\/sj.onc.1204506","article-title":"Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H: quinone oxidoreductase1 gene","volume":"20","author":"Dhakshinamoorthy","year":"2001","journal-title":"Oncogene"},{"issue":"36","key":"10.1016\/j.aohep.2019.11.010_bib0590","doi-asserted-by":"crossref","first-page":"13079","DOI":"10.3748\/wjg.v20.i36.13079","article-title":"Role of Nrf2 in chronic liver disease","volume":"20","author":"Tang","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.aohep.2019.11.010_bib0595","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.bpg.2010.08.005","article-title":"Nonalcoholic fatty liver disease","volume":"24","author":"Krawczyk","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.aohep.2019.11.010_bib0600","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/10408363.2011.596521","article-title":"Non-alcoholic fatty liver disease","volume":"48","author":"Smith","year":"2011","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1\u20132","key":"10.1016\/j.aohep.2019.11.010_bib0605","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cccn.2004.12.022","article-title":"Glutathione metabolism and antioxidant enzymes in patients affected by nonalcoholic steatohepatitis","volume":"355","author":"Nobili","year":"2005","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.aohep.2019.11.010_bib0610","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/CS20030285","article-title":"Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients","volume":"106","author":"Videla","year":"2004","journal-title":"Clin Sci"},{"issue":"2","key":"10.1016\/j.aohep.2019.11.010_bib0615","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3164\/jcbn.12-101","article-title":"Effects of tocotrienol on tumor necrosis factor-\u03b1\/d-galactosamine-induced steatohepatitis in rats","volume":"52","author":"Yachi","year":"2013","journal-title":"J Clin Biochem Nutr"},{"issue":"3","key":"10.1016\/j.aohep.2019.11.010_bib0620","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s11892-013-0372-1","article-title":"Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis","volume":"13","author":"Gupte","year":"2013","journal-title":"Curr Diab Rep"},{"issue":"15.","key":"10.1016\/j.aohep.2019.11.010_bib0625","article-title":"Systemic activation of NRF2 alleviates lethal autoimmune inflammation in scurfy mice","volume":"37","author":"Suzuki","year":"2017","journal-title":"Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.aohep.2019.11.010_bib0630","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.gene.2016.03.058","article-title":"Small Maf proteins (MafF, MafG MafK): history, structure and function","volume":"586","author":"Katsuoka","year":"2016","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.aohep.2019.11.010_bib0635","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1128\/MCB.01204-10","article-title":"SCF\/-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a keap1-independent manner","volume":"31","author":"Rada","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.aohep.2019.11.010_bib0640","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","article-title":"Nrf2 signaling pathway: pivotal roles in inflammation","author":"Ahmed","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"10.1016\/j.aohep.2019.11.010_bib0645","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.46.120604.141046","article-title":"Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway","volume":"47","author":"Kensler","year":"2007","journal-title":"Annu Rev Pharmacool Toxicol"},{"issue":"38","key":"10.1016\/j.aohep.2019.11.010_bib0650","doi-asserted-by":"crossref","first-page":"15259","DOI":"10.1073\/pnas.1305687110","article-title":"Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex","volume":"110","author":"Baird","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.aohep.2019.11.010_bib0655","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.3390\/ijms18122772","article-title":"Nrf2, the master regulator of anti-oxidative responses","volume":"18","author":"Vomund","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"15","key":"10.1016\/j.aohep.2019.11.010_bib0660","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1128\/MCB.22.15.5492-5505.2002","article-title":"Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound","volume":"22","author":"Braun","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.aohep.2019.11.010_bib0665","first-page":"143","article-title":"The relationship between Helicobacter pylori infection and promoter polymorphism of the Nrf2 gene in the chronic gastritis","volume":"19","author":"Arisawa","year":"2007","journal-title":"Int J Mol Med"},{"issue":"1.","key":"10.1016\/j.aohep.2019.11.010_bib0670","article-title":"Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.aohep.2019.11.010_bib0675","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","article-title":"The interaction of hepatic lipid and glucose metabolism in liver diseases","volume":"56","author":"Bechmann","year":"2012","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2019.11.010_bib0680","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1172\/JCI25790","article-title":"Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis","volume":"116","author":"Thimmulappa","year":"2006","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.aohep.2019.11.010_bib0685","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.4049\/jimmunol.0901754","article-title":"Innate immunity against bacterial infection following hyperoxia exposure is impaired in NRF2-deficient mice","volume":"183","author":"Reddy","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.aohep.2019.11.010_bib0690","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.freeradbiomed.2009.04.033","article-title":"Nrf2 is a critical modulator of the innate immune response in a model of uveitis","volume":"47","author":"Nagai","year":"2009","journal-title":"Free Radic Biol Med"},{"issue":"1\u20132","key":"10.1016\/j.aohep.2019.11.010_bib0695","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mrfmmm.2009.09.007","article-title":"A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders","volume":"690","author":"Kim","year":"2010","journal-title":"Mutat Res\/Fundam Mol Mech Mutagene"},{"issue":"11\u201312","key":"10.1016\/j.aohep.2019.11.010_bib0700","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1089\/ars.2005.7.1674","article-title":"Molecular mechanisms involved in enhancing HO-1 expression: de-repression by heme and activation by Nrf2 the \u201cone-two\u201d punch","volume":"7","author":"Srisook","year":"2005","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"10.1016\/j.aohep.2019.11.010_bib0705","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1124\/pr.55.3.5","article-title":"Different faces of the heme-heme oxygenase system in inflammation","volume":"55","author":"Wagener","year":"2003","journal-title":"Pharmacol Rev"},{"issue":"4","key":"10.1016\/j.aohep.2019.11.010_bib0710","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2353\/ajpath.2008.070863","article-title":"Heme oxygenase-1 prevents airway mucus hypersecretion induced by cigarette smoke in rodents and humans","volume":"173","author":"Almolki","year":"2008","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.aohep.2019.11.010_bib0715","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/ATVBAHA.107.160085","article-title":"Far infrared therapy inhibits vascular endothelial inflammation via the induction of heme oxygenase-1. Arteriosclerosis","volume":"28","author":"Lin","year":"2008","journal-title":"Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.aohep.2019.11.010_bib0720","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejphar.2007.12.004","article-title":"The involvement of heme oxygenase-1 activity in the therapeutic actions of 5-aminosalicylic acid in rat colitis","volume":"581","author":"Horv\u00e1th","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"25","key":"10.1016\/j.aohep.2019.11.010_bib0725","first-page":"159","article-title":"The role of Nrf2 in cellular innate immune response to inflammatory injury","volume":"4","author":"Kim","year":"2009","journal-title":"J Korean Soc Toxicol"},{"key":"10.1016\/j.aohep.2019.11.010_bib0730","series-title":"Free radicals in biology and medicine","author":"Halliwell","year":"2007"},{"issue":"16","key":"10.1016\/j.aohep.2019.11.010_bib0735","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1161\/CIRCULATIONAHA.106.664250","article-title":"Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice","volume":"115","author":"Lewis","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.aohep.2019.11.010_bib0740","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.freeradbiomed.2004.04.010","article-title":"Role of Se-dependent glutathione peroxidases in gastrointestinal inflammation and cancer","volume":"36","author":"Chu","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.aohep.2019.11.010_bib0745","first-page":"1151","article-title":"Inmunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25) Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Inmunol"},{"issue":"12","key":"10.1016\/j.aohep.2019.11.010_bib0750","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1681\/ASN.2014100978","article-title":"T lymphocyte-specific activation of Nrf2 protects from AKI","volume":"26","author":"Noel","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.aohep.2019.11.010_bib0755","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.4049\/jimmunol.1101712","article-title":"Th2 skewing by activation of Nrf2 in CD4+ T cells","volume":"188","author":"Rockwell","year":"2012","journal-title":"Am J Immunol"},{"key":"10.1016\/j.aohep.2019.11.010_bib0760","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cca.2015.07.009","article-title":"Natural Nrf2 activators in diabetes","volume":"448","author":"Jim\u00e9nez-Osorio","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.aohep.2019.11.010_bib0765","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.bbrc.2019.04.144","article-title":"Hepatocellular iNOS protects liver from NASH through Nrf2-dependent activation of HO-1","volume":"514","author":"Qiao","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"10.1016\/j.aohep.2019.11.010_bib0770","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1111\/liv.13860","article-title":"Nonalcoholic fatty liver disease is associated with decreased lung function","volume":"38","author":"Lee","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2019.11.010_bib0775","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.redox.2018.04.002","article-title":"High circulatory leptin mediated NOX-2-peroxynitrite-miR21 axis activate mesangial cells and promotes renal inflammatory pathology in nonalcoholic fatty liver disease","volume":"17","author":"Alhasson","year":"2018","journal-title":"Redox Biol"},{"issue":"4","key":"10.1016\/j.aohep.2019.11.010_bib0780","doi-asserted-by":"crossref","first-page":"585","DOI":"10.5604\/01.3001.0012.0922","article-title":"Impact of diabetes mellitus and insulin on nonalcoholic fatty liver disease in the morbidly obese","volume":"17","author":"Strey","year":"2018","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.aohep.2019.11.010_bib0785","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.freeradbiomed.2013.08.174","article-title":"Free radical biology for medicine: learning from nonalcoholic fatty liver disease","volume":"65","author":"Serviddio","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.aohep.2019.11.010_bib0790","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/597134","article-title":"The dual role of Nrf2 in nonalcoholic fatty liver disease: regulation of antioxidant defenses and hepatic lipid metabolism","volume":"2015","author":"Chambel","year":"2015","journal-title":"BioMed Res Int"},{"issue":"4","key":"10.1016\/j.aohep.2019.11.010_bib0795","doi-asserted-by":"crossref","first-page":"E710","DOI":"10.1152\/ajpendo.00052.2019","article-title":"Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2\u03b1\/PPAR\u03b1 pathway","volume":"317","author":"Chen","year":"2019","journal-title":"Am J Physiol-Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.aohep.2019.11.010_bib0800","doi-asserted-by":"crossref","first-page":"1700903","DOI":"10.1002\/mnfr.201700903","article-title":"Sugary kefir strain Lactobacillus mali APS1 ameliorated hepatic steatosis by regulation of SIRT-1\/Nrf-2 and gut microbiota in rats","volume":"62","author":"Chen","year":"2018","journal-title":"Mol Nutr Food Res"},{"issue":"9","key":"10.1016\/j.aohep.2019.11.010_bib0805","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1039\/C9FO01373C","article-title":"High-fat diet induces mouse liver steatosis with a concomitant decline in energy metabolism: attenuation by eicosapentaenoic acid (EPA) or hydroxytyrosol (HT) supplementation and the additive effects upon EPA and HT co-administration","volume":"10","author":"Echeverr\u00eda","year":"2019","journal-title":"Food Funct"},{"issue":"8","key":"10.1016\/j.aohep.2019.11.010_bib0810","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.metabol.2016.02.014","article-title":"Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease","volume":"65","author":"Mota","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.aohep.2019.11.010_bib0815","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0022-2275(20)39055-6","article-title":"Uptake and metabolism of triglycerides by the rat liver","volume":"1","author":"Stein","year":"1960","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.aohep.2019.11.010_bib0820","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: a major mediator of non-alcoholic fatty liver disease","volume":"68","author":"Jensen","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2019.11.010_bib0825","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.freeradbiomed.2018.12.034","article-title":"Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: a mechanism involving Toll-like receptor 4 and oxidative stress","volume":"134","author":"Chenxu","year":"2019","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.aohep.2019.11.010_bib0830","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3803\/EnM.2019.34.1.39","article-title":"Implications of mitochondrial unfolded protein response and mitokines: a perspective on fatty liver diseases","volume":"34","author":"Yi","year":"2019","journal-title":"Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.aohep.2019.11.010_bib0835","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1053\/j.gastro.2007.10.039","article-title":"Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease","volume":"134","author":"Puri","year":"2008","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.aohep.2019.11.010_bib0840","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10620-018-5290-2","article-title":"CircScd1 promotes fatty liver disease via the janus kinase 2\/signal transducer and activator of transcription 5 pathway","volume":"64","author":"Li","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.aohep.2019.11.010_bib0845","article-title":"Hepatic growth hormone \u2013 JAK2 \u2013 STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression","author":"Kaltenecker","year":"2018","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.aohep.2019.11.010_bib0850","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41575-019-0144-8","article-title":"Past, present and future perspectives in nonalcoholic fatty liver disease","volume":"16","author":"Sanyal","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2019.11.010_bib0855","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2011.10.003","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis","volume":"52","author":"Rolo","year":"2012","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"10.1016\/j.aohep.2019.11.010_bib0860","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.aohep.2019.11.010_bib0865","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1572-0241.2007.01709.x","article-title":"Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment","volume":"103","author":"Carter-Kent","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.aohep.2019.11.010_bib0870","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.21635","article-title":"Hepatocyte-specific Gclc deletion leads to rapid onset of steatosis with mitochondrial injury and liver failure","volume":"45","author":"Chen","year":"2007","journal-title":"Hepatology"},{"issue":"14","key":"10.1016\/j.aohep.2019.11.010_bib0875","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.1128\/MCB.25.14.5933-5946.2005","article-title":"Nrf1 and Nrf2 regulate rat glutamate-cysteine ligase catalytic subunit transcription indirectly via NF-\u03baB and AP-1","volume":"25","author":"Yang","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"14","key":"10.1016\/j.aohep.2019.11.010_bib0880","doi-asserted-by":"crossref","first-page":"12029","DOI":"10.1074\/jbc.M211558200","article-title":"Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis","volume":"278","author":"Lee","year":"2003","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.aohep.2019.11.010_bib0885","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1021\/tx050217c","article-title":"The role of Keap1 in cellular protective responses","volume":"18","author":"Dinkova-Kostova","year":"2005","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"10.1016\/j.aohep.2019.11.010_bib0890","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev.pharmtox.43.100901.140229","article-title":"Regulatory mechanisms controlling gene expression mediated by the antioxidant response element","volume":"43","author":"Nguyen","year":"2003","journal-title":"Annu Rev Pharmacool Toxicol"},{"issue":"6","key":"10.1016\/j.aohep.2019.11.010_bib0895","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/carcin\/bgp100","article-title":"Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice","volume":"30","author":"Yates","year":"2009","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.aohep.2019.11.010_bib0900","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.taap.2010.03.016","article-title":"Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet","volume":"245","author":"Zhang","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"10.1016\/j.aohep.2019.11.010_bib0905","doi-asserted-by":"crossref","first-page":"440","DOI":"10.5009\/gnl18382","article-title":"Improvement of nonalcoholic fatty liver disease reduces the risk of type 2 diabetes mellitus","volume":"13","author":"Cho","year":"2019","journal-title":"Gut Liver"},{"issue":"2","key":"10.1016\/j.aohep.2019.11.010_bib0910","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.freeradbiomed.2009.11.007","article-title":"Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis","volume":"48","author":"Chowdhry","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.aohep.2019.11.010_bib0915","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2001-12929","article-title":"Mitochondria in steatohepatitis","volume":"21","author":"Pessayre","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.aohep.2019.11.010_bib0920","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008571-200401000-00001","article-title":"Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomeclanture recommendations for genes, pseudogenes and alternative-splice variants","volume":"14","author":"Nelson","year":"2004","journal-title":"Pharmacogenetics"},{"issue":"2","key":"10.1016\/j.aohep.2019.11.010_bib0925","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/hep.510270217","article-title":"Cytochrome P4502A6 (CYP2A6) expression in human hepatocellular carcinoma","volume":"27","author":"Raunio","year":"1998","journal-title":"Hepatology"},{"issue":"01.","key":"10.1016\/j.aohep.2019.11.010_bib0930","article-title":"Role of nuclear factor erythroid 2-like 2 in the induction of cytochrome P450 2a5 in vivo of nonalcoholic fatty liver disease","volume":"06","author":"Qiuju Wang","year":"2015","journal-title":"J Diab Metab"},{"key":"10.1016\/j.aohep.2019.11.010_bib0935","unstructured":"IQ DII initiative. https:\/\/www.iqdili.org [accessed 15.09.19]."},{"issue":"4","key":"10.1016\/j.aohep.2019.11.010_bib0940","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/pds.1211","article-title":"Hy's law: predicting serious hepatotoxicity","volume":"15","author":"Temple","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.aohep.2019.11.010_bib0945","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/hep.510270121","article-title":"Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis","volume":"27","author":"Weltman","year":"1998","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.aohep.2019.11.010_bib0950","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1021\/acs.molpharmaceut.8b00159","article-title":"Nonalcoholic fatty liver disease and diabetes are associated with decreased CYP3A4 protein expression and activity in human liver","volume":"15","author":"Jamwal","year":"2018","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1016\/j.aohep.2019.11.010_bib0955","doi-asserted-by":"crossref","first-page":"e0198139","DOI":"10.1371\/journal.pone.0198139","article-title":"Elevated Nrf-2 responses are insufficient to mitigate protein carbonylation in hepatospecific PTEN deletion mice","volume":"13","author":"Petersen","year":"2018","journal-title":"PLOS ONE"},{"issue":"1","key":"10.1016\/j.aohep.2019.11.010_bib0960","doi-asserted-by":"crossref","first-page":"e0146337","DOI":"10.1371\/journal.pone.0146337","article-title":"The selective SGLT2 inhibitor ipragliflozin has a therapeutic effect on nonalcoholic steatohepatitis in mice","volume":"11","author":"Honda","year":"2016","journal-title":"PLOS ONE"},{"issue":"1","key":"10.1016\/j.aohep.2019.11.010_bib0965","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-19658-7","article-title":"Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH","volume":"8","author":"Shiba","year":"2018","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.aohep.2019.11.010_bib0970","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00125-018-4675-2","article-title":"Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study","volume":"61","author":"Eriksson","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.aohep.2019.11.010_bib0975","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.curtheres.2017.07.002","article-title":"Effects of dapagliflozin on body composition and liver tests in patients with nonalcoholic steatohepatitis associated with type 2 diabetes mellitus: a prospective, open-label uncontrolled study","volume":"87","author":"Tobita","year":"2017","journal-title":"Curr Therap Res"},{"issue":"10","key":"10.1016\/j.aohep.2019.11.010_bib0980","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc17-0518","article-title":"Comparison of ipragliflozin and pioglitazone effects on nonalcoholic fatty liver disease in patients with type 2 diabetes: a randomized, 24-week open-label, active-controlled trial","volume":"40","author":"Ito","year":"2017","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.aohep.2019.11.010_bib0985","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2337\/dc18-0165","article-title":"Effect of empagliflozin on liver fat in patients with type 2 diabetes and nonalcoholic fatty liver disease: a randomized controlled trial (E-LIFT trial)","volume":"41","author":"Kuchay","year":"2018","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.aohep.2019.11.010_bib0990","doi-asserted-by":"crossref","first-page":"e0166125","DOI":"10.1371\/journal.pone.0166125","article-title":"Benefits and harms of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"11","author":"Storgaard","year":"2016","journal-title":"PLOS ONE"},{"issue":"1","key":"10.1016\/j.aohep.2019.11.010_bib0995","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/hepr.13236","article-title":"Effect of luseogliflozin on hepatic fat content in type 2 diabetes patients with non-alcoholic fatty liver disease: a prospective, single-arm trial (LEAD trial)","volume":"49","author":"Sumida","year":"2018","journal-title":"Hepatol Res"},{"issue":"10","key":"10.1016\/j.aohep.2019.11.010_bib1000","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.cellsig.2011.05.016","article-title":"Modulation of Nrf2 expression alters high glucose-induced oxidative stress and antioxidant gene expression in mouse mesangial cells","volume":"23","author":"Li","year":"2011","journal-title":"Cell Signal"},{"key":"10.1016\/j.aohep.2019.11.010_bib1005","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2337\/db10-1164","article-title":"Diabetic Downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in in vivo","volume":"60","author":"Tan","year":"2011","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.aohep.2019.11.010_bib1010","doi-asserted-by":"crossref","first-page":"H1133","DOI":"10.1152\/ajpheart.00402.2010","article-title":"Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia","volume":"300","author":"Ungvari","year":"2011","journal-title":"Am J Physiol-Heart Circ Physiol"},{"issue":"11","key":"10.1016\/j.aohep.2019.11.010_bib1015","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1158\/0008-5472.CAN-04-4539","article-title":"The synthetic triterpenoids, CDDO and CDDO-imidazolide are potent inducers of heme oxygenase-1 and Nrf2\/ARE signaling","volume":"65","author":"Liby","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.aohep.2019.11.010_bib1020","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2443.2008.01234.x","article-title":"Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice","author":"Yoh","year":"2008","journal-title":"Genes Cells"},{"key":"10.1016\/j.aohep.2019.11.010_bib1025","article-title":"Liraglutide reduces hepatic glucolipotoxicity-induced liver cell apoptosis through NRF2 signaling in Zucker diabetic fatty rats","author":"Guo","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.aohep.2019.11.010_bib1030","first-page":"1","article-title":"Curcumin and \u03b1\/\u03b2-adrenergic antagonists cotreatment reverse liver cirrhosis in hamsters: participation of Nrf-2 and NF-\u03baB","author":"Mac\u00edas-P\u00e9rez","year":"2019","journal-title":"J Immunol Res"},{"issue":"4","key":"10.1016\/j.aohep.2019.11.010_bib1035","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1177\/0748233713502841","article-title":"Protective effects of silymarin against acetaminophen-induced hepatotoxicity and nephrotoxicity in mice","volume":"32","author":"Bektur","year":"2013","journal-title":"Toxicol Ind Health"},{"key":"10.1016\/j.aohep.2019.11.010_bib1040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.fct.2017.01.021","article-title":"Silymarin protects against acrylamide-induced neurotoxicity via Nrf2 signalling in PC12 cells","volume":"102","author":"Li","year":"2017","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"10.1016\/j.aohep.2019.11.010_bib1045","first-page":"149","article-title":"The effect of resveratrol on oxidative stress in the liver and serum of a rat model of polycystic ovary syndrome: an experimental study","volume":"16","author":"Ghowsi","year":"2018","journal-title":"Int J Reprod BioMed"},{"issue":"1","key":"10.1016\/j.aohep.2019.11.010_bib1050","first-page":"684","article-title":"Effects of resveratrol on the Nrf2 and HO-1 expression in diabetic vascular endothelial cells","volume":"10","author":"Wang","year":"2017","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.aohep.2019.11.010_bib1055","article-title":"Resveratrol protects against oxidative stress by activating the Keap-1\/Nrf2 antioxidant defense system in obese-asthmatic rats","author":"Li","year":"2018","journal-title":"Exp Therap Med"},{"key":"10.1016\/j.aohep.2019.11.010_bib1060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.biopha.2015.03.008","article-title":"Chemopreventive role of anthocyanins in atherosclerosis via activation of Nrf2-ARE as an indicator and modulator of redox","volume":"72","author":"Aboonabi","year":"2015","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"10.1016\/j.aohep.2019.11.010_bib1065","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1089\/jmf.2017.4102","article-title":"Black radish (Raphanus sativus L. var. niger) extract mediates its hepatoprotective effect on carbon tetrachloride-induced hepatic injury by attenuating oxidative stress","volume":"21","author":"Ahn","year":"2018","journal-title":"J Med Food"},{"key":"10.1016\/j.aohep.2019.11.010_bib1070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2015.12.008","article-title":"Suppression of NRF2-ARE activity sensitizes chemotherapeutic agent-induced cytotoxicity in human acute monocytic leukemia cells","volume":"292","author":"Peng","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"issue":"7","key":"10.1016\/j.aohep.2019.11.010_bib1075","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1507\/endocrj.EJ16-0542","article-title":"Active form of vitamin D ameliorates non-alcoholic fatty liver disease by alleviating oxidative stress in a high-fat diet rat model","volume":"64","author":"Zhu","year":"2017","journal-title":"Endocr J"},{"issue":"2","key":"10.1016\/j.aohep.2019.11.010_bib1080","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.freeradbiomed.2005.08.043","article-title":"The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy","volume":"40","author":"Nelson","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.aohep.2019.11.010_bib1085","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1002\/eji.200526116","article-title":"Activation of the Nrf2\/antioxidant response pathway increases IL-8 expression","volume":"35","author":"Zhang","year":"2005","journal-title":"Eur J Immunol"},{"issue":"04","key":"10.1016\/j.aohep.2019.11.010_bib1090","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1055\/s-0033-1358522","article-title":"The unfolded protein response in fatty liver disease","volume":"33","author":"Green","year":"2013","journal-title":"Semin Liver Dis"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526811932294X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526811932294X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:42:46Z","timestamp":1761648166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S166526811932294X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":109,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S166526811932294X"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2019.11.010","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NRF-2 and nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2019.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}